Literature DB >> 22473002

Refined staging for chorioretinopathy in long-chain 3-hydroxyacyl coenzyme A dehydrogenase deficiency.

Tiina Tyni1, Tuuli Immonen, Päivi Lindahl, Anna Majander, Tero Kivelä.   

Abstract

OBJECTIVE: Neonatal screening and earlier diagnosis have improved the prognosis of long-chain 3-hydroxyacyl coenzyme A dehydrogenase (LCHAD) deficiency, which causes a need to refine the staging of the pigmentary chorioretinopathy and thus improve monitoring and comparability of patients under dietary therapy.
METHODS: Seven children with LCHAD deficiency caused by homozygous G1528C mutation attended sequential fundus photography for stage 2 chorioretinopathy in 1997–2006. After arranging 21 pairs of fund us photographs according to the severity of the fundus changes,the images best representing 3 different grades of pigmentary deposits (P1–P3) and retinal pigment epithelial(RPE) atrophy (A1–A3) were chosen as reference photographs.To evaluate the substaging, 29 pairs of photographs were graded according to the reference photographs.
RESULTS: In the assessment of pigmentary deposits, the 3 ophthalmologists agreed in 41% and differed by a single substage in 45% of instances (combined weighted ĸ statistic was 0.38, indicating moderate agreement). In pairwise comparisons,the weighted ĸ statistic ranged from 0.31 to 0.56 (agreement, 71–81%). In the assessment of RPE atrophy, all 3 raters agreed in 17% and 2 raters in 70% of instances (combined ĸ statistic 0.018, indicating poor agreement). DISCUSSION: Despite variation in imaging techniques and limitations in the visual assessment of fundus photographs, the agreement obtained in grading the pigmentary deposits was comparable to that reported for photographic grading of retinopathy of prematurity. We recommend photographic documentation and substaging based on reference photographs in the follow-up of LCHAD retinopathy. The refined staging allows a more detailed assessment on the progression of the retinopathy and optimization of the therapeutic protocols in individual patients and between centres using different therapeutic protocols.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22473002     DOI: 10.1159/000334874

Source DB:  PubMed          Journal:  Ophthalmic Res        ISSN: 0030-3747            Impact factor:   2.892


  4 in total

1.  Characterization of Chorioretinopathy Associated with Mitochondrial Trifunctional Protein Disorders: Long-Term Follow-up of 21 Cases.

Authors:  Erin A Boese; Nieraj Jain; Yali Jia; Catie L Schlechter; Cary O Harding; Simon S Gao; Rachel C Patel; David Huang; Richard G Weleber; Melanie B Gillingham; Mark E Pennesi
Journal:  Ophthalmology       Date:  2016-08-02       Impact factor: 12.079

2.  A novel HADHA variant associated with an atypical moderate and late-onset LCHAD deficiency.

Authors:  Anne-Frédérique Dessein; Eléonore Hebbar; Joseph Vamecq; Elodie Lebredonchel; Aurore Devos; Jamal Ghoumid; Karine Mention; Dries Dobbelaere; Marie Joncquel Chevalier-Curt; Monique Fontaine; Sabine Defoort; Vassily Smirnov; Claire Douillard; Claire-Marie Dhaenens
Journal:  Mol Genet Metab Rep       Date:  2022-03-15

3.  Sports in LCHAD Deficiency: Maximal Incremental and Endurance Exercise Tests in a 13-Year-Old Patient with Long-Chain 3-Hydroxy Acyl-CoA Dehydrogenase Deficiency (LCHADD) and Heptanoate Treatment.

Authors:  D Karall; G Mair; U Albrecht; K Niedermayr; T Karall; W Schobersberger; S Scholl-Bürgi
Journal:  JIMD Rep       Date:  2014-07-06

4.  Clinical outcome, biochemical and therapeutic follow-up in 14 Austrian patients with Long-Chain 3-Hydroxy Acyl CoA Dehydrogenase Deficiency (LCHADD).

Authors:  Daniela Karall; Michaela Brunner-Krainz; Katharina Kogelnig; Vassiliki Konstantopoulou; Esther M Maier; Dorothea Möslinger; Barbara Plecko; Wolfgang Sperl; Barbara Volkmar; Sabine Scholl-Bürgi
Journal:  Orphanet J Rare Dis       Date:  2015-02-22       Impact factor: 4.123

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.